Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-4,971
Closed -$125K 10771
2013
Q4
$125K Buy
4,971
+1,371
+38% +$32.3K ﹤0.01% 5814
2013
Q3
$83K Sell
3,600
-357
-9% -$8.13K ﹤0.01% 6234
2013
Q2
$81K Buy
+3,957
New +$75K ﹤0.01% 6155

Other funds holding SNV

UBS's SNV Position: Q3 2014 in Review

UBS reduced its Synovus (SNV) stake by 18% in Q3 2014, selling an estimated $539K and leaving 105,052 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

UBS first reported a position in SNV in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.11M in Q2 2014. 235 funds tracked by Wall St. Rank hold SNV as of Q3 2014.

  • UBS held 105,052 shares of Synovus worth $2.48M as of Q3 2014.
  • UBS sold 22,497 Synovus shares in Q3 2014, an estimated $539K.
  • Synovus made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2698 holding.
  • UBS first reported a position in Synovus in Q2 2013 and has held it in 6 quarters since.
  • UBS's Synovus position peaked at $3.11M in Q2 2014.
  • 235 funds tracked by Wall St. Rank held Synovus as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.